+#RCT in #dermatomyositis with #brepocitinib Oral #TYK2/JAK1i 241 pts +outcomes #TIS total improvement score >40%TIS 68% v 44% #steroid tapering #skin improved rapidly #CLASI #OP0166 #POS0264 @RheumNow #EULAR2026 https://t.co/9WZl9RsXXe